Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: December 16, 2019

DrugPatentWatch Database Preview

Litigation Details for Allkem Laboratories Limited v. NPS Pharmaceuticals, Inc (N.D. Ill. 2013)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Allkem Laboratories Limited v. NPS Pharmaceuticals, Inc (N.D. Ill. 2013)

Docket   Start Trial Date Filed 2013-09-10
Court District Court, N.D. Illinois Date Terminated 2013-11-04
Cause 28:2201 Declaratory Judgement (Insurance) Assigned To Edmond E-Min Chang
Jury Demand None Referred To
Patents 6,071,970
Attorneys Brendan Francis Barker; Christopher B Essig; Imron T Aly; Jeffrey Mark Drake; Ryan Christopher Williams
Firms Akerman LLP; Miller, Canfield, Paddock and Stone; Schiff Hardin LLP; Winston & Strawn; Winston and Strawn LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Allkem Laboratories Limited v. NPS Pharmaceuticals, Inc
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Allkem Laboratories Limited v. NPS Pharmaceuticals, Inc (N.D. Ill. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-09-10 1 States Patent and Trademark Office (“USPTO”) issued U.S. Patent No. 6,071,970 (“the ‘970 patent”) on June…disclosed patents actually cover the drug or method of using such drug, or whether the patent is valid…of the ‘970 patent against Alkem. Alkem requested a covenant not to sue on the ‘970 patent, to resolve…resolve any patent dispute since NPS chose not to sue Alkem on the patent, but was unable to reach an agreement…expired, with no patent infringement suit filed against Alkem regarding the ‘970 patent, Alkem now has External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.